- Jaime K. Pickett, DVM, MBA, joined PetVivo Holdings’ board of directors effective Sept. 22.
- Pickett has more than 20 years of experience in veterinary healthcare and animal health.
- She currently serves as chief medical officer of EQUUSIR USA and advising chief medical officer and a board member of Alexander International Innovations.
- Her previous leadership positions include roles with Hannah Pet Hospitals, Pet Paradise and NewDay Veterinary Care.
- Pickett fills the board vacancy created by the resignation of Diane Levitan.
- PetVivo’s board continues to consist of six directors following the changes.
PetVivo Holdings has appointed veterinary healthcare executive Jaime K. Pickett, DVM, MBA, to its board of directors, effective Sept. 22.
Pickett brings more than two decades of experience in animal health, multi-site veterinary operations, corporate strategy, business development and product commercialization.
PetVivo said her experience in clinical practice, hospital operations and animal health technology will support the company as it works to expand product adoption and its relationships with veterinary professionals.
“We are pleased to welcome Dr. Jaime Pickett to PetVivo’s Board of Directors,” said John Lai, CEO of PetVivo Holdings. Lai said Pickett brings a combination of veterinary experience, executive leadership and experience growing veterinary care organizations.
Experience across veterinary operations and technology
Pickett currently serves as chief medical officer of EQUUSIR USA. She is also advising chief medical officer and a board member of Alexander International Innovations, where she provides guidance related to clinical, regulatory, commercialization and strategic matters for medical and animal health technologies.
She also serves on the Board of Chief Veterinary Medical Officers and is a multi-unit Scenthound franchisee.
From 2023 to 2026, Pickett held several executive positions with Hannah Pet Hospitals, including CEO, president, chief strategy officer and board member.
Previously, she served from 2017 to 2022 as chief veterinary officer and senior vice president of Pet Paradise and chief operating officer of its NewDay Veterinary Care subsidiary. In those roles, she worked across more than 55 pet resorts and veterinary hospitals in more than 15 states and directed teams of more than 100 veterinary professionals.
Her experience also includes veterinary practice ownership, multi-site expansion, mergers and acquisitions evaluation and telehealth implementation.
Pickett earned her Doctor of Veterinary Medicine from the University of Florida College of Veterinary Medicine and an MBA from St. George’s University. She holds a bachelor’s degree from Johns Hopkins University and completed the Global C-Suite Program through Wharton Executive Education at the University of Pennsylvania.
Board remains at six directors
Pickett fills the vacancy created by Diane Levitan’s resignation, which also took effect Sept. 22. Following the changes, PetVivo’s board continues to have six directors.
PetVivo develops and commercializes medical devices, biomaterials and therapeutics for animal and human health. Its lead commercial product, SPRYNG with OsteoCushion technology, is a veterinarian-administered intra-articular injection used for management of lameness and other joint-related conditions, including osteoarthritis, in cats, dogs and horses.
Information sourced from the company’s press release.
